As the world's largest extract manufacturer, ALK exemplifies the spirit of scientific leadership. Each year, we reinvest 20% of revenue back into allergy research and we continue to support clinical studies worldwide to evaluate allergen specific immunotherapy.
Our dedication to scientific advancement goes beyond research and includes a commitment to providing quality extracts, products and services. To learn more about our commitment to quality in our extract manufacturing, please refer to our Quality Brochure in the material list.
Together, we can focus on the diagnosis and treatment strategies that target the underlying mechanism of allergic disease.